Dr. DeVito is a physician-scientist at Duke University studying the interactions between cancer and the immune system. His research focuses on how cancer metastasizes and evades the immune system in the process, particularly dendritic cells. Dr. DeVito first became interested in tumor immunology and immunotherapy as an undergraduate at the University of South Florida, where he also completed medical school. He then went on to train in internal medicine and complete his fellowship in Hematology/Oncology at Duke University. Dr. DeVito is currently a member of the Brent Hanks' lab at Duke and is a Medical Instructor in the Division of Medical Oncology, treating patients with gastrointestinal cancers including colorectal cancer, pancreatic cancer, and esophageal cancer. The goals of his work are to translate laboratory findings into meaningful outcomes for patients, bring clinical research questions back to the laboratory, and to develop novel immunotherapies and immune biomarkers.